Skip to main content
. Author manuscript; available in PMC: 2016 Jul 27.
Published in final edited form as: Mol Pharm. 2015 Apr 28;12(6):2010–2018. doi: 10.1021/mp5008212

Figure 7.

Figure 7

Tumor growth inhibition and downregulation of intratumoral R2 expression in Kasumi-1 xenograft tumor-bearing mice. Tumor-bearing mice (n = 4) were treated with various formulations of GTI-2040 (3 mg/kg), as described in Materials and Methods. (A) Inhibition of tumor growth. (B) Intratumoral R2 mRNA expression.